title: Agency is under fire for refusing to supply details of sudden deaths after first dose of multiple sclerosis drug.
authors.forename: Jacqui
authors.initials: J
authors.lastname: Wise
mesh_terms: D003645:Death, Sudden; D030881:Disclosure; D064420:Drug-Related Side Effects and Adverse Reactions; D005060:Europe; D000068876:Fingolimod Hydrochloride; D006077:Government Agencies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine